After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours.
Stocks Info
This NYSE-listed company operates within the Household & Personal Products industry segment, falling under the Consumer Defensive sector. The current market capitalization of Nu Skin Enterprises, Inc is $405.74M. A total of 0.78 million shares were traded on the day, compared to an average of 774.65K shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, NUS has seen 0 BUY and 0 SELL insider trades, representing the acquisition of 0 and the disposition of 0 shares. Over the last 12 months, there were 0 BUYs and 0 SELLs from insiders. Insiders purchased 0 shares during that period but sold 0.
In the most recent transaction, Battle Emma S. sold 1,693 shares of NUS for 7.73 per share on Feb 21 ’25. After the transaction, the Director now owns 17,530 company shares. In a previous transaction on Feb 21 ’25, Battle Emma S. bought 1,693 shares at 7.73 per share.
Among the insiders who sold shares, LIPMAN ANDREW D disposed of 2,000 shares on May 28 ’24 at a per-share price of $13.33. This resulted in the Director holding 23,225 shares of NUS after the transaction. In another insider transaction, WOODBURY EDWINA D sold 1,693 shares at $12.02 per share on May 02 ’24. Company shares held by the Director now total 18,095.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. NUS’s most recent ex-dividend date was 3.2% when it declared a $0.06 quarterly dividend that was paid in cash on 2/24/2025. Previously, the company paid the dividend on 11/29/2024 with an ex-dividend date of 3.8%. The NUS stock dividend was $0.06 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for NUS in the last 3 months, the mean price target is $7.25 with high estimates of $7.50 and low estimates of $7.00. In terms of 52-week highs and lows, NUS has a high of $14.04 and a low of $5.95.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. NUS’s latest balance sheet shows that the firm has $354.81M in Cash & Short Term Investments as of fiscal 2021. There were $503.79M in debt and $529.69M in liabilities at the time. Its Book Value Per Share was $13.08, while its Total Shareholder’s Equity was $912.77M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for NUS is Buy with a score of 3.00.
